Mark K. Weng

981 total citations · 1 hit paper
24 papers, 478 citations indexed

About

Mark K. Weng is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mark K. Weng has authored 24 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 17 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Mark K. Weng's work include Hepatitis Viruses Studies and Epidemiology (15 papers), Hepatitis B Virus Studies (13 papers) and Hepatitis C virus research (6 papers). Mark K. Weng is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (15 papers), Hepatitis B Virus Studies (13 papers) and Hepatitis C virus research (6 papers). Mark K. Weng collaborates with scholars based in United States, United Kingdom and Canada. Mark K. Weng's co-authors include Noele P. Nelson, Mona Doshani, Kelly L. Moore, José R. Romero, Megan G. Hofmeister, Sarah Schillie, Alaya Koneru, Aaron M. Harris, Eric Hall and Liesl M. Hagan and has published in prestigious journals such as Hepatology, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Mark K. Weng

23 papers receiving 463 citations

Hit Papers

Universal Hepatitis B Vaccination in Adults Aged 19–59 Ye... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
    2022 110 citations Mark K. Weng, Mona Doshani et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Mark K. Weng
Mona Doshani United States
Freke Zuure Netherlands
Melissa G. Collier United States
Christine Larsen France
Gayle E. Fischer United States
Adriano Grossi Italy
Gerusa Maria Figueiredo Brazil
Nedret Emiroğlu Denmark
Andrea Gabbuti Italy
Cuauhtémoc Ruiz‐Matus United States
Mona Doshani United States
Mark K. Weng
Citations per year, relative to Mark K. Weng Mark K. Weng (= 1×) peers Mona Doshani

Countries citing papers authored by Mark K. Weng

Since Specialization
Citations

This map shows the geographic impact of Mark K. Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Weng more than expected).

Fields of papers citing papers by Mark K. Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark K. Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Weng. The network helps show where Mark K. Weng may publish in the future.

Co-authorship network of co-authors of Mark K. Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Mark K. Weng. A scholar is included among the top collaborators of Mark K. Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark K. Weng. Mark K. Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ly, Kathleen N., Justin K. Niles, Ruth Jiles, et al.. (2024). Hepatitis C Virus Testing, Infection, and Cases Reported Through Public Health Surveillance During Expanded Screening Recommendations, United States, 2013-2021. Public Health Reports. 2071016839–2071016839. 3 indexed citations
2.
Lo, Nathan C., Emmanuelle A. Dankwa, Christl A. Donnelly, et al.. (2023). Determining Herd Immunity Thresholds for Hepatitis A Virus Transmission to Inform Vaccination Strategies Among People Who Inject Drugs in 16 US States. Clinical Infectious Diseases. 78(4). 976–982. 2 indexed citations
3.
Hofmeister, Megan G., Shaoman Yin, Noele P. Nelson, Mark K. Weng, & Neil Gupta. (2023). Trends and Opportunities: Hepatitis A Virus Infection, Seroprevalence, and Vaccination Coverage—United States, 1976-2020. Public Health Reports. 2070976647–2070976647. 6 indexed citations
4.
Weng, Mark K., Mona Doshani, Mohammed A. Khan, et al.. (2022). Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022. American Journal of Transplantation. 22(6). 1714–1720. 10 indexed citations
5.
Bruce, Michael G., Dana Bruden, Debby Hurlburt, et al.. (2022). Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose. Hepatology. 76(4). 1180–1189. 31 indexed citations
6.
Weng, Mark K., Mona Doshani, Mohammed A. Khan, et al.. (2022). Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR Morbidity and Mortality Weekly Report. 71(13). 477–483. 110 indexed citations breakdown →
7.
8.
Montgomery, Martha P., Yuna Zhong, Alice Asher, et al.. (2022). Vaccination barriers and opportunities at syringe services programs in the United States, June–August 2021—A cross-sectional survey. Drug and Alcohol Dependence. 237. 109540–109540. 16 indexed citations
9.
Carry, Monique, et al.. (2022). Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews. Harm Reduction Journal. 19(1). 100–100. 7 indexed citations
10.
Dankwa, Emmanuelle A., Christl A. Donnelly, Andrew F. Brouwer, et al.. (2021). Estimating vaccination threshold and impact in the 2017–2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States. Vaccine. 39(49). 7182–7190. 6 indexed citations
11.
Hofmeister, Megan G., Mark K. Weng, Douglas Thoroughman, et al.. (2021). Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016–2019. Vaccine. 39(44). 6460–6463. 1 indexed citations
12.
Koneru, Alaya, et al.. (2021). National Perinatal Hepatitis B Prevention Program: 2009–2017. PEDIATRICS. 147(3). 8 indexed citations
13.
14.
Hofmeister, Megan G., Jian Xing, Monique A. Foster, et al.. (2020). Factors Associated With Hepatitis A Mortality During Person‐to‐Person Outbreaks: A Matched Case–Control Study—United States, 2016‐2019. Hepatology. 74(1). 28–40. 17 indexed citations
15.
Hofmeister, Megan G., Jian Xing, Monique A. Foster, et al.. (2020). Hepatitis A Person-to-Person Outbreaks: Epidemiology, Morbidity Burden, and Factors Associated With Hospitalization—Multiple States, 2016–2019. The Journal of Infectious Diseases. 223(3). 426–434. 33 indexed citations
16.
Weng, Mark K., Richard Brooks, Janet Glowicz, et al.. (2019). Outbreak investigation of Pseudomonas aeruginosa infections in a neonatal intensive care unit. American Journal of Infection Control. 47(9). 1148–1150. 13 indexed citations
17.
Chae, Sae‐Rom, Anna Q. Yaffee, Mark K. Weng, et al.. (2018). Notes from the Field: Investigation of Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Among Patients at a Community Hospital — Kentucky, 2016. MMWR Morbidity and Mortality Weekly Report. 66(5152). 1410–1410. 4 indexed citations
18.
Weng, Mark K., Susan Hocevar Adkins, Monica M. Farley, et al.. (2017). Risk Factors for Community-Associated Clostridium difficile Infection in Children. Open Forum Infectious Diseases. 4(suppl_1). S677–S678. 1 indexed citations
19.
Weng, Mark K., et al.. (2016). Ophthalmic Considerations in Stevens-Johnson Syndrome. The Journal of Pediatrics. 175. 235–235. 2 indexed citations
20.
Branch, William T., et al.. (2012). Teaching compassion. Patient Education and Counseling. 89(1). 3–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona Doshani Breakdown of academic impact, for papers by Freke Zuure Breakdown of academic impact, for papers by Melissa G. Collier Breakdown of academic impact, for papers by Christine Larsen Breakdown of academic impact, for papers by Gayle E. Fischer Breakdown of academic impact, for papers by Adriano Grossi Breakdown of academic impact, for papers by Gerusa Maria Figueiredo Breakdown of academic impact, for papers by Nedret Emiroğlu Breakdown of academic impact, for papers by Andrea Gabbuti Breakdown of academic impact, for papers by Cuauhtémoc Ruiz‐Matus
Rankless by CCL
2026